Welcome to YLOAN.COM
yloan.com » Health » Brazil's Biopharmaceutical Sector Contributes To Economic Growth, Expands Access To Healthcare
Health Medical Acne Aerobics-Cardio Alternative Anti-Aging Build-Muscle Chronic-Illness Dental-Care Depression Diabetes Disability Exercise Eye-Care Fitness-Equipment Hair-Loss Medicine Meditation Nutrition Obesity Polution Quit-Smoking Sidha Supplements Yeast Infection H1N1 Swine Flu SARS herpes therapy panic surgeon hurts teeth remedies eliminate chiropractic arthritis ingredients syndrome binding anxiety surgery medication psychic dental reflux doctor relief premature emotional stress disorder implants wrinkles vision infection aging liposuction seattle stunning sweating hair treatment tinnitus

Brazil's Biopharmaceutical Sector Contributes To Economic Growth, Expands Access To Healthcare

(1888PressRelease) Global Health Progress highlights how Brazil's investment in research

and development promotes innovation and helps drive the economy.

Washington, DC-MD-VA-WV - Global Health Progress (GHP) released a new report that reveals how the biopharmaceutical sector in Brazil, the tenth largest biopharmaceutical market in the world and the largest in Latin America, is an important driver for its economy. For instance, Brazil's biopharmaceutical sector develops high-quality, highly skilled jobs, which is a key factor in creating a stable economy. Currently, approximately 821 biotechnology companies in Brazil employ almost 100,000 people with an average annual salary of approximately US $4,457. Among those companies, six biopharmaceutical companies were featured in a 2003 list of the top 100 companies to work for in Brazil.

Not only does the biopharmaceutical sector produce valuable job opportunities for highly skilled workers, this emerging market plays a critical role in fostering public-private partnerships, which leads to more economic growth and greater access to healthcare for its citizens.

Investment in research and development (R&D) and promoting innovation are key ways the Brazilian government is helping drive future growth of the country's biopharmaceutical sector. For instance, R&D investments in Brazil have increased to 1.5% of GDP in 2010 and there are more than 205 highly trained physicians per 100,000 of the population serving as investigators for clinical studies.


"In Brazil, promoting innovation is a public policy priority," stated Rafael Oliva, Advisor to the Presidency at the Brazilian Development Bank. "The participation of the Brazilian government in research and development (R&D) is considerable, and the goal is to both increase innovative activities in Brazil on a systematic basis, and to consolidate the country's culture of innovation."

GHP fact sheet shows how Brazil's investment in research and development (R&D) will create positive effects throughout the economy, including improving access to healthcare for its citizens through the production of new medicines. The growing field of clinical trials is also a significant factor in improving access to healthcare. Brazil's large population of 190 million people, with 8 out of every 10 residents living in or near a city, means clinical trial recruitment and participation is fairly robust.

Brazil's robust investment in promoting innovation is contributing to the global expansion of the biopharmaceutical sector, which in turn creates a positive effect on the overarching global health goals of fostering global competitiveness, reducing the health and economic burden of disease on local citizens, developing tomorrow's medicines and expanding access to healthcare. Please view full PDF for additional information and list of sources.

About Global Health Progress:

Global Health Progress also supports efforts to raise awareness and mobilize resources to address health challenges in the developing world by bringing local leaders together with international health experts, policymakers, donor governments, and the private sector.


On the Web: www.globalhealthprogress.org / twitter.com/globalhealth / facebook.com/group.php?gid=35156473766 / linkedin.com/groups?home=&gid=2972068

Source:

http://www.1888pressrelease.com/brazil-s-biopharmaceutical-sector-contributes-to-economic-gr-pr-244364.html

by: Alberto Stellpflug
Winter Styling With Trendy Suede Jackets Safe and Effective Sexual Enhancement Herbs How To Take Care Of Rabbits During Winter High Blood Pressure And The Effects Of Alcohol Never too Old to Sex - Sexual Health and Old Age Plastic surgery can reconstruct your body part Body lift surgery From Realbellezza There are Better Ways Than BMI to Measure Health Global Health Progress agrees criticizing "Big Pharma" is not the answer Bodybuilding Routines That Function - 6 Issues To Know To Help Obtain Muscle Arthritis Causes and Herbal Remedies That You Should Know The High Blood Pressure Remedy Report Total Body Workout And Power Pops The Best Way To Lose Weight Fast
print
www.yloan.com guest:  register | login | search IP(216.73.216.75) California / Anaheim Processed in 0.019435 second(s), 5 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 24 , 3561, 61,
Brazil's Biopharmaceutical Sector Contributes To Economic Growth, Expands Access To Healthcare Anaheim